Functional Testing of Health Supplements for Visual Fatigue Relief: Standards, Methods, and Human Tr

Visual fatigue relief is one of the fastest-growing functional claims in the eye health supplement market, driven by formulas built around lutein, zeaxanthin, anthocyanins, astaxanthin, and omega-3 fatty acids. Credible substantiation of this claim requires a complete testing chain, including ingredient identification, potency verification, safety screening, and randomized placebo-controlled human trials, performed in accredited third-party laboratories under recognized standards such as GB, ISO/IEC 17025, and AOAC methods. This article provides a technical walkthrough of the sample types, testing items, analytical methods, and regulatory applications involved in evaluating the visual fatigue relief function of health supplements.

Technical Overview

Visual fatigue, clinically referred to as asthenopia, is a common condition caused by prolonged near-vision work, extended screen exposure, and reduced blink rates. Typical symptoms include eye dryness, soreness, blurred vision, eye strain, photophobia, and accompanying headache or discomfort around the eyes. Health supplements targeting visual fatigue relief are typically formulated with nutrients that support macular pigment density, accommodation function, retinal microcirculation, and ocular antioxidant defense.

Functional testing for visual fatigue relief claims follows a three-tier framework. The first tier verifies the identity, purity, and potency of the declared active ingredients using validated instrumental methods. The second tier confirms product safety through hygiene, contaminant, and stability testing in accordance with national food safety standards such as the GB series. The third tier, and the most decisive one, is the human efficacy trial, which must be designed as a randomized, double-blind, placebo-controlled feeding study conducted under ethical oversight in accordance with the Declaration of Helsinki and relevant national functional evaluation guidelines.

In markets where "alleviating visual fatigue" is a regulated health function claim, such as China's health food registration system, positive human trial results are a mandatory prerequisite for claim approval. In other jurisdictions, the same data package serves as the scientific substantiation required for structure-function claims. All analytical and clinical work should be performed by accredited third-party laboratories operating under an ISO/IEC 17025 quality management system to ensure data integrity and regulatory acceptance.

Testing Samples

Carotenoid-Based Eye Formulas

Products formulated with lutein, zeaxanthin, or meso-zeaxanthin derived from marigold (Tagetes erecta) extracts are the most common category. Both free-form xanthophylls and esterified forms are submitted, and laboratories must confirm the active isomer profile as well as total carotenoid content before any efficacy evaluation begins.

Berry and Anthocyanin Extract Products

Bilberry, blueberry, blackcurrant, and chokeberry extracts are widely used for their anthocyanin content, which is associated with improved retinal microcirculation and rhodopsin regeneration. Testing focuses on total monomeric anthocyanin content, individual anthocyanin glycoside profiling, and detection of adulteration with synthetic dyes.

Marine and Algal Actives

Fish oil, algal oil rich in DHA, and astaxanthin from Haematococcus pluvialis are submitted for fatty acid profiling, astaxanthin ester quantification, and oxidation indicator testing, including peroxide value and acid value, which are critical quality attributes for lipid-based ingredients.

Vitamin, Mineral, and Compound Formulas

Compound products containing vitamin A or beta-carotene, B-complex vitamins, vitamin C, vitamin E, zinc, selenium, taurine, and traditional botanical ingredients are tested for each declared nutrient at label claim level, plus uniformity of dosage units across the batch.

Dosage Forms and Sampling Requirements

Accepted dosage forms include softgels, hard capsules, tablets, granules, powders, gummies, and oral liquids. Standard sampling for a complete evaluation typically requires:

• Three independent production batches for quality and stability testing
• A minimum of 100 to 200 dosage units per batch for physicochemical and microbiological analysis
• Sufficient finished product and matching placebo, in original packaging, for the full human trial duration plus reserve
• Retention samples held under accelerated and long-term storage conditions for shelf-life verification

Testing Items

A complete visual fatigue relief function evaluation covers four categories of testing items.

Identity and Potency Testing

• Total lutein and zeaxanthin content, including free versus ester distribution
• Total monomeric anthocyanins and individual glycoside profile
• Astaxanthin content and isomeric composition
• Fatty acid composition, DHA and EPA levels, and oxidation indicators
• Declared vitamins and minerals versus label claims
• Botanical marker compounds for traditional herbal ingredients

Safety and Hygiene Testing

• Heavy metals and harmful elements: lead, arsenic, mercury, and cadmium
• Microbiological indicators: total plate count, coliforms, molds and yeasts, Salmonella, Staphylococcus aureus, and Bacillus cereus
• Mycotoxins such as aflatoxins where botanical ingredients are present
• Residual solvents, pesticide residues, and illegal adulterants
• Capsule shell parameters such as chromium for gelatin-based shells

Stability Testing

• Accelerated testing at elevated temperature and humidity conditions
• Long-term real-time testing under proposed storage conditions
• Active ingredient retention rate, degradation profiling, and shelf-life confirmation

Human Efficacy Endpoints

• Visual fatigue symptom scores covering eye dryness, eye distension, eye soreness, blurred vision, and photophobia
• Distance and near visual acuity measured with standard logarithmic charts
• Positive afterimage duration, also known as visual persistence, reflecting visual function endurance
• Blink frequency and tear film break-up time as supportive dryness indicators
• Accommodation function indicators such as near point of accommodation
• Safety monitoring parameters including hematology, liver and kidney function, blood pressure, and urinalysis

Testing Methods

Physicochemical and Ingredient Analysis

Carotenoids such as lutein and zeaxanthin are quantified by high-performance liquid chromatography with ultraviolet or photodiode array detection, following validated national methods such as those in the GB 5009 series or equivalent AOAC official methods. Anthocyanins are measured by the pH differential spectrophotometric method for total monomeric content and confirmed by HPLC for glycoside profiles. Astaxanthin and DHA are analyzed by HPLC and gas chromatography respectively. Heavy metals are determined by inductively coupled plasma mass spectrometry or atomic absorption spectrometry, and microbiological testing follows the GB 4789 series of national standard methods.

Human Efficacy Trial Protocol

The core efficacy study is a randomized, double-blind, placebo-controlled parallel-group feeding trial. The standard protocol includes:

• Recruitment of adult volunteers, typically aged 18 to 65, with confirmed visual fatigue symptoms arising from prolonged screen or near-vision work
• Exclusion of subjects with organic eye disease, recent ocular surgery, uncorrected refractive error, systemic conditions affecting vision, or current use of interfering eye medications
• A run-in period to establish baseline symptom scores and objective indicators
• A daily intervention period of 30 to 60 days with the test product or an identical placebo
• Baseline and endpoint measurements of symptom scores, visual acuity, positive afterimage duration, and supportive ocular indicators by ophthalmic professionals under controlled lighting conditions
• Concomitant recording of diet, screen time, and lifestyle confounders throughout the trial

Efficacy Judgment Criteria

A positive result generally requires that the test group shows a statistically significant reduction in total visual fatigue symptom score compared with the placebo group, supported by improvement in at least one objective indicator such as visual acuity or positive afterimage duration, with no deterioration in any measured parameter. Statistical analysis applies paired and independent sample tests, with non-parametric alternatives for ordinal symptom data, at a significance level of 0.05. Dropouts, adverse events, and protocol deviations are documented in full to support data credibility.

Ethical and Quality Assurance Requirements

All human trials must receive prior approval from an independent ethics committee, obtain written informed consent from every participant, and be registered where applicable. Analytical work must be conducted under an ISO/IEC 17025 accredited quality system, with method validation, chain-of-custody documentation, and instrument calibration records maintained throughout.

Applications

Testing data packages for visual fatigue relief function serve multiple commercial and regulatory purposes:

• Registration dossiers for health food function claims in regulated markets, where human trial reports are a mandatory submission component
• Scientific substantiation files for structure-function claims and label statements in international markets
• Marketing substantiation required by e-commerce platforms, retailers, and advertising review authorities
• Import and export compliance documentation for cross-border trade of finished supplements and raw extracts
• In-process quality control and batch release testing for contract manufacturers and brand owners
• Research and development support for dose-finding, formulation comparison, and ingredient supplier qualification
• Shelf-life justification and post-market surveillance for stability and consistency verification

FAQ

Is a human clinical trial mandatory for a visual fatigue relief claim?

Yes, in markets where visual fatigue relief is a regulated health function, a positive randomized, double-blind, placebo-controlled human feeding trial is mandatory for claim approval. In markets with structure-function claim frameworks, the same human trial data provides the highest level of substantiation and significantly reduces regulatory and advertising compliance risk.

What ingredients must be verified before starting the human trial?

All declared actives, such as lutein, zeaxanthin, anthocyanins, astaxanthin, DHA, vitamins, and minerals, should be quantified against label claims, and the batch must pass microbiological, heavy metal, and contaminant screening. Safety confirmation of the trial batch is an ethical prerequisite before any volunteer consumes the product.

How many samples and batches are required?

Typically three production batches are needed for quality and stability testing, with 100 to 200 dosage units per batch for laboratory analysis. The human trial requires sufficient finished product and matching placebo for the full intervention period covering all enrolled subjects, plus an overage for reserve and retention.

How long does the complete evaluation take?

Physicochemical and safety testing generally takes two to four weeks per batch. The human efficacy trial, including ethics approval, recruitment, a 30 to 60 day intervention, and statistical reporting, typically requires four to six months. Accelerated stability testing requires at least three to six months, while long-term shelf-life verification runs in parallel with the proposed product lifespan.

What determines a successful test outcome?

A successful outcome requires a statistically significant improvement in visual fatigue symptom scores in the test group versus placebo, supported by improvement in at least one objective ophthalmic indicator, together with absence of clinically relevant safety findings in the monitoring data.

Do imported products need the same testing?

Imported products seeking function claim registration in the destination market must meet the same evaluation requirements as domestic products, including ingredient verification and human trial data generated under recognized ethical and quality standards, usually with additional documentation of origin and manufacturing compliance.